UCB’s approach to scientific innovation is a key area of our sustainability approach and underpins our commitment to make a positive impact for people living with severe diseases. In line with UN SDG #3, which aims to ensure healthy lives and promote wellbeing for all, we are working to create value for patients, now and into the future – and in doing so, to contribute to the wider health and wellbeing of our societies for generations to come.
By focusing on developing differentiated solutions for specific patient populations, regardless of size, we are taking tangible steps forward by moving from symptomatic treatment to disease modification, and eventually, towards cures for severe chronic diseases. To achieve this goal, we continue to focus on patients’ unmet needs and expanding our capabilities by investing in state-of-the-art scientific platforms and medical advances.
The journey towards differentiated solutions for specific patients starts early in research and development. Our research process is grounded in strong science. We aim to understand the evolving knowledge underpinning disease biology and combine this with groundbreaking technologies and platforms to develop novel therapies.
Please note that innovation-related risks are reported in the Risk Management section of this report.